SUPPORT for Patients and Communities Reauthorization Act of 2025

The SUPPORT for Patients and Communities Reauthorization Act of 2025 is a broad reauthorization and funding package aimed at extending and expanding federal programs that prevent opioid use disorder (OUD), improve treatment, and support recovery. It also adds new or expanded initiatives in areas such as fetal alcohol spectrum disorders (FASD), trauma-informed care, mental health, and youth prevention. The bill increases or extends funding through fiscal years 2026–2030 for numerous prevention, treatment, and recovery activities, while adding new requirements, studies, and interagency coordination (including cybersecurity measures for the Suicide Prevention Lifeline and a fentanyl-focused interagency work group). In short, it broadens the scope of opioid-related efforts beyond the core addiction interventions to include trauma, maternal health, child health, mental health, and community recovery while promoting state flexibility and open standards in some programs. Key elements include expanded financing for prevention, treatment, and recovery programs; new FASD prevention and support activities; promotion of state choice in PDMPs and other open standards; enhanced first responder training and broader drug overdose prevention; cybersecurity protections for the 9-8-8 Suicide Lifeline; a federal interagency work group on fentanyl contamination; updated guidance on at-home drug disposal; and greater emphasis on trauma-informed care, research, and workforce development. The bill also modernizes several existing programs—such as residential treatment for pregnant women, addiction medicine access, loan repayment for SUD treatment professionals, and SUD patient records training—while adding scheduling reviews for buprenorphine/naloxone products and related oversight.